Showing results (141-150 of 198) with videos related to
Sort By:
Pageof 20
Genes, Chromosomes & Cancer|July 25, 2019
Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUGα) in neuroblastoma patient samples with chromosome arm 2p rearrangementsNiloufar Javanmardi, Susanne Fransson, Anna Djos, et al.International Journal of Cancer|September 6, 2012
Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivoMalin Wickström, Cecilia Dyberg, Takashi Shimokawa, et al.Proceedings of the National Academy of Sciences of the United States of America|July 12, 2017
Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppressionIsabelle Westerlund, Yao Shi, Konstantinos Toskas, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 8, 2026
Surveillance adherence and clinical findings in children with confirmed or familial TP53 variants: the Swedish multicenter constitutional TP53 study (SWEP53)Alexander Sun Zhang, Meis Omran, Joakim Wille, et al.Journal of Molecular Neuroscience : MN|September 7, 2006
Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide geneRadmila Santic, Katrin Fenninger, Kerstin Graf, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivoFrida Ponthan, Malin Wickström, Helena Gleissman, et al.Neuro-Oncology Advances|December 11, 2024
Genomic tumor evolution dictates human medulloblastoma progressionYana Ruchiy, Ioanna Tsea, Efthalia Preka, et al.Plos One|January 18, 2018
Doxorubicin-provoked increase of mitotic activity and concomitant drain of G0-pool in therapy-resistant BE(2)-C neuroblastomaIsabell Hultman, Linnea Haeggblom, Ingvild Rognmo, et al.Genes, Chromosomes & Cancer|September 25, 2014
Intragenic anaplastic lymphoma kinase (ALK) rearrangements: translocations as a novel mechanism of ALK activation in neuroblastoma tumorsSusanne Fransson, Magnus Hansson, Kristina Ruuth, et al.Cancer Research|November 10, 2010
Appearance of the novel activating F1174S ALK mutation in neuroblastoma correlates with aggressive tumor progression and unresponsiveness to therapyTommy Martinsson, Therese Eriksson, Jonas Abrahamsson, et al.Pageof 20